Aclaris Therapeutics Stock Quote ACRS - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.46

Bid

1.45

Ask

1.47

Volume

2,539,055

1.33 Day's Range 1.37

0.5902 52 Week Range 11.12

Market Cap

96.207M

Previous Close

1.35

Open

1.35

Last Trade

121

1.46

(formt)

Last Trade Time

Financial Volume

$ 3,423,173

VWAP

1.3482

Average Volume (3m)

714,027

Shares Outstanding

71,264,786

Dividend Yield

PE Ratio

-1.07

Earnings Per Share (EPS)

-1.24

Revenue

31.25M

Net Profit

-88.48M

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from... Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from the contract research segment, which provides laboratory services. Its drug candidates under development are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138 is an ITJ Inhibitor; and ATI-1777. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aclaristx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Aclaris Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ACRS. The last closing price for Aclaris Therapeutics was $1.35. Over the last year, Aclaris Therapeutics shares have traded in a share price range of $ 0.5902 to $ 11.12.

Aclaris Therapeutics currently has 71,264,786 shares outstanding. The market capitalization of Aclaris Therapeutics is $96.21 million. Aclaris Therapeutics has a price to earnings ratio (PE ratio) of -1.07.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.16	12.3076923077	1.3	1.37	1.2495	690693	1.28725167	CS
4	0.34	30.3571428571	1.12	1.37	1.1	790883	1.2120696	CS
12	0.21	16.8	1.25	1.4035	0.9515	714027	1.18536811	CS
26	0.4	37.7358490566	1.06	1.51	0.9515	1006256	1.20053372	CS
52	-9.47	-86.6422689844	10.93	11.12	0.5902	1934259	1.84303027	CS
156	-13.8	-90.4325032765	15.26	19.97	0.5902	1012502	5.76291118	CS
260	-0.75	-33.9366515837	2.21	30.375	0.5902	1036618	7.46350208	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SILOSilo Pharma Inc	$ 2.38 (122.43%)	176.2M
TKLFYoshitsu Company Ltd	$ 0.6117 (99.74%)	318.3M
NAASNaaS Technology Inc	$ 4.6301 (65.36%)	22.46M
ATGLAlpha Technology Group Limited	$ 4.18 (47.18%)	920.43k
LCFYLocafy Ltd	$ 5.34 (46.30%)	6.5M
JEWLAdamas One Corporation	$ 0.33 (-25.88%)	275.38k
AEHLAntelope Enterprise Holdings Ltd	$ 4.04 (-21.86%)	488.93k
AMIXAutonomix Medical Inc	$ 1.09 (-21.01%)	6.99M
ASLNASLAN Pharmaceuticals Ltd	$ 1.10 (-20.29%)	599.54k
CYNCYNGN Inc	$ 7.3799 (-19.61%)	1.16M
TKLFYoshitsu Company Ltd	$ 0.6117 (99.74%)	318.3M
MAXNMaxeon Solar Technologies Ltd	$ 0.2524 (11.19%)	246.54M
NVDANVIDIA Corporation	$ 126.36 (-1.62%)	214.77M
SILOSilo Pharma Inc	$ 2.38 (122.43%)	176.2M
SQQQProShares UltraPro Short QQQ	$ 7.46 (0.00%)	130.14M